Achaogen News
10/07/2011
Plazomicin Shows Promise as New Aminoglycoside Antibiotic
"Plazomicin, an investigational aminoglycoside previously know as ACHN-490, is a promising new agent for treating gram-negative infections, according to George G. Zhanel, Ph.D."
Doug Brunk
Family Practice News
October 7, 2011
03/22/2011
Achaogen Appoints Kenneth J. Hillan, M.B. Ch.B., to Chief Medical Officer
- Dr. Hillan Brings Significant Experience in Pipeline Strategy and Global Drug Development -
Scientific & General Publications/Posters
10/01/2011
Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals
Tenover, FC; Tickler, I; Armstrong, ES; Kubo, A; Lopez, S; Persing, DH; Miller, GH
International journal of antimicrobial agents 2011;38(4):352-4.
Access this publication at sciencedirect.com [purchase or paid subscription required]
09/29/2011
Emergence of an Autochthonous and Community-Acquired NDM-1–Producing Klebsiella pneumoniae in Europe
Patrice Nordmann, Jean-Pierre Couard, Dominique Sansot, and Laurent Poirel
Clin Infect Dis. (2011) doi: 10.1093/cid/cir720
Access this publication at cid.oxfordjournals.org
09/21/2011
In Vivo Activity of Plazomicin (previously ACHN-490) Against Causative Agents of Nosocomial Pneumonia in a Murine Neutropenic Lung Model
N Reyes, JV McKinnell, RD Matias, LA Feeney, RT Cass, and RT Cirz
Achaogen Inc.
ICAAC 2011, poster # A2-045c
[ more posters / scientific publications ]
Bacterial Resistance in the News
10/29/2011
Warm Weather Increases Hospital Infections, And What That Might Mean For Climate Change
'“If average temperatures are rising (independent of cause), then we would expect to see more Gram-negative infections in the future,” lead author Eli Perencevich told me by email. “This could mean more difficult-to-treat infections, and also higher likelihood of outbreaks when temperatures are warm.”'
Maryn McKenna
Maryn McKenna
Wired
October 29, 2011
10/01/2011
Resistance Is Futile
"We won’t stop the rising tide of infections until we develop a new business model to fight them."
By MEGAN MCARDLE
By MEGAN MCARDLE
The Atlantic
October, 2011
Read more...
Read more...
